FIELD: pharmacology.
SUBSTANCE: invention relates to compounds of formula (I)
,
in which radicals and characters have values specified in the claims and their versions. The proposed compounds act as potent antagonists of CCR (9) receptor. Animal testing has shown that these compounds are useful for treatment of inflammation, disease with a hallmark for CCR (9). The compounds as a whole are arylsulfamide derivatives and are used in pharmaceutical compositions, methods for treatment of CCR (9) mediated diseases and as a control in assays for identification of CCR (9) antagonists.
EFFECT: increased efficiency of compounds application.
26 cl, 2 tbl, 33 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PROCESS FOR PREPARATION OF 1-ACYL-4-PHENYLSULFONYLPROLINAMIDE DERIVATIVES AND NEW INTERMEDIATES | 2012 |
|
RU2615997C2 |
| COMPOUNDS OF THIENOPYRIMIDINE | 2013 |
|
RU2637925C2 |
| ACTIVE COMPOUNDS WITH RESPECT TO BROMO-DOMAINS | 2015 |
|
RU2743074C2 |
| 6-ARYL-4-MORPHOLINE-1-YL PYRIDONES SUITABLE FOR TREATMENT OF CANCER OR DIABETES | 2017 |
|
RU2754664C2 |
| ESTROGEN RECEPTOR MODULATORS | 2017 |
|
RU2738646C2 |
| SUBSTITUTED PYRAZOLONE COMPOUNDS AND METHODS OF USE | 2013 |
|
RU2650895C2 |
| NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVES AND USE THEREOF IN PHARMACEUTICAL PREPARATIONS | 2013 |
|
RU2701156C2 |
| ANTAGONISTS OF CHEMOKINE RECEPTORS | 2013 |
|
RU2646762C2 |
| CXCR7 ANTAGONISTS | 2013 |
|
RU2649004C2 |
| DERIVATIVES OF 5-MEMBER HETEROCYCLES AS KINASE p38 INHIBITORS | 2004 |
|
RU2381219C2 |
